Log In
BCIQ
Print this Print this
 

IBSchek Blood Test

  Manage Alerts
Collapse Summary General Information
Company Commonwealth Laboratories Inc.
DescriptionELISA-based blood test that detects antibodies against cytolethal distending toxin B (CdtB) and vinculin (VCL) within 24 hours to diagnose irritable bowel syndrome (IBS)
Molecular Target Cytolethal distending toxin B (CdtB) ; Vinculin (VCL)
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationIrritable bowel syndrome
Indication DetailsDiagnose Irritable bowel syndrome (IBS)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/23/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today